Caelum Diagnostic Solutions is a seed-stage digital biopsy diagnostics company. Our CEO, Dr. Rachel Wellner, a breast surgical oncologist, has devised a technology which renders a biopsy evaluation in less than 10 minutes, with 94%-99% accuracy, while the patient is still on the procedure table. The Company’s initial target market is the breast cancer space but the technology has wider global application in other cancer indications.
Industry: Medical Equipment Manufacturing
Company Size: 11-50 employees